Forte Biosciences, Inc.
USD17.29
+0.29 (+1.68%)
CEO
Paul A. Wagner
IPO Date
2017-04-13
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$17.05
Prev. Close
$17.00
Day Low
$16.80
Day High
$17.39
52W Low
$9.10
52W High
$35.80
Market Cap
$0.24B
Volume
0.03M
| 18,353 |
| $0.00 |
| 2 Jun 2026 | VINCENT RICHARD G | director | A-Award | Acquired | 18,353 | $0.00 |
| 2 Jun 2026 | GRYSKA DAVID W | director | A-Award | Acquired | 18,353 | $0.00 |
| 2 Jun 2026 | Brun Scott C. | director | A-Award | Acquired | 18,353 | $0.00 |
| 2 Jun 2026 | Kornfeld Steven | director | A-Award | Acquired | 18,353 | $0.00 |
| 3 Apr 2026 | Riley Antony A | CHIEF FINANCIAL OFFICER | M-Exempt | Acquired | 375 | $0.00 |
| 3 Apr 2026 | Riley Antony A | CHIEF FINANCIAL OFFICER | F-InKind | Disposed | 134 | $24.86 |
| 3 Apr 2026 | Riley Antony A | CHIEF FINANCIAL OFFICER | M-Exempt | Disposed | 375 | $0.00 |
| 3 Apr 2026 | Wagner Paul A. | director, officer: SEE REMARKS | M-Exempt | Acquired | 1,250 | $0.00 |